Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
Protecting the heart during cancer treatment Advances in oncology have significantly improved survival rates for people with cancer. However, some cancer therapies can affect cardiovascular health, a phenomenon known as cardiotoxicity. This potential impact on the heart has become one of the main challenges in cardio-oncology, a field focused on preventing, detecting, and treating cardiovascular […]
